Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Development of the TypeSeq Assay for Detection of 51 Human Papillomavirus Genotypes by Next-Generation Sequencing.

Wagner S, Roberson D, Boland J, Yeager M, Cullen M, Mirabello L, Dunn ST, Walker J, Zuna R, Schiffman M, Wentzensen N.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e01794-18. doi: 10.1128/JCM.01794-18. Print 2019 May.

PMID:
30814267
2.

Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis.

Conrad RD, Liu AH, Wentzensen N, Zhang RR, Dunn ST, Wang SS, Schiffman M, Gold MA, Walker JL, Zuna RE.

Cancer Cytopathol. 2018 Nov;126(11):950-958. doi: 10.1002/cncy.22055. Epub 2018 Oct 23.

3.

A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers.

Wentzensen N, Walker J, Smith K, Gold MA, Zuna R, Massad LS, Liu A, Silver MI, Dunn ST, Schiffman M.

Am J Obstet Gynecol. 2018 Jun;218(6):604.e1-604.e8. doi: 10.1016/j.ajog.2018.02.009. Epub 2018 Feb 17.

PMID:
29462629
4.

Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.

Liu AH, Walker J, Gage JC, Gold MA, Zuna R, Dunn ST, Schiffman M, Wentzensen N.

Obstet Gynecol. 2017 Dec;130(6):1218-1225. doi: 10.1097/AOG.0000000000002330.

5.

Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.

Clarke MA, Luhn P, Gage JC, Bodelon C, Dunn ST, Walker J, Zuna R, Hewitt S, Killian JK, Yan L, Miller A, Schiffman M, Wentzensen N.

Int J Cancer. 2017 Aug 15;141(4):701-710. doi: 10.1002/ijc.30781. Epub 2017 May 26.

6.

Comparison of Colposcopic Impression Based on Live Colposcopy and Evaluation of Static Digital Images.

Liu AH, Gold MA, Schiffman M, Smith KM, Zuna RE, Dunn ST, Gage JC, Walker JL, Wentzensen N.

J Low Genit Tract Dis. 2016 Apr;20(2):154-61. doi: 10.1097/LGT.0000000000000194.

7.

Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer.

Bodelon C, Vinokurova S, Sampson JN, den Boon JA, Walker JL, Horswill MA, Korthauer K, Schiffman M, Sherman ME, Zuna RE, Mitchell J, Zhang X, Boland JF, Chaturvedi AK, Dunn ST, Newton MA, Ahlquist P, Wang SS, Wentzensen N.

Carcinogenesis. 2016 Feb;37(2):188-196. doi: 10.1093/carcin/bgv171. Epub 2015 Dec 9. No abstract available.

8.

Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods.

Castro FA, Koshiol J, Quint W, Wheeler CM, Gillison ML, Vaughan LM, Kleter B, van Doorn LJ, Chaturvedi AK, Hildesheim A, Schiffman M, Wang SS, Zuna RE, Walker JL, Dunn ST, Wentzensen N.

BMC Infect Dis. 2015 Nov 25;15:544. doi: 10.1186/s12879-015-1281-5.

9.

Multiple biopsies and detection of cervical cancer precursors at colposcopy.

Wentzensen N, Walker JL, Gold MA, Smith KM, Zuna RE, Mathews C, Dunn ST, Zhang R, Moxley K, Bishop E, Tenney M, Nugent E, Graubard BI, Wacholder S, Schiffman M.

J Clin Oncol. 2015 Jan 1;33(1):83-9. doi: 10.1200/JCO.2014.55.9948. Epub 2014 Nov 24.

10.

Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer.

Zhao L, Wentzensen N, Zhang RR, Dunn ST, Gold MA, Wang SS, Schiffman M, Walker JL, Zuna RE.

Cancer Cytopathol. 2014 Sep;122(9):694-701. doi: 10.1002/cncy.21443. Epub 2014 May 28.

11.

Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic.

Sahasrabuddhe VV, Gravitt PE, Dunn ST, Robbins D, Brown D, Allen RA, Eby YJ, Smith KM, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N.

J Clin Virol. 2014 Aug;60(4):414-7. doi: 10.1016/j.jcv.2014.04.016. Epub 2014 May 2.

12.

Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic.

Sahasrabuddhe VV, Gravitt PE, Dunn ST, Brown D, Allen RA, Eby YJ, Smith K, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N.

J Clin Microbiol. 2014 Jan;52(1):187-92. doi: 10.1128/JCM.01623-13. Epub 2013 Nov 6.

13.

The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features.

Cykowski MD, Allen RA, Kanaly AC, Fung KM, Marshall R, Perry A, Stolzenberg ED, Dunn ST.

J Neurooncol. 2013 Dec;115(3):477-86. doi: 10.1007/s11060-013-1249-5. Epub 2013 Sep 21.

PMID:
24057326
14.

Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study.

Koshiol J, Sklavos M, Wentzensen N, Kemp T, Schiffman M, Dunn ST, Wang SS, Walker JL, Safaeian M, Zuna RE, Hildesheim A, Pfeiffer RM, Pinto LA.

Int J Cancer. 2014 Jan 15;134(2):411-25. doi: 10.1002/ijc.28354. Epub 2013 Jul 30.

15.

Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results.

Luhn P, Houldsworth J, Cahill L, Schiffman M, Castle PE, Zuna RE, Dunn ST, Gold MA, Walker J, Wentzensen N.

Gynecol Oncol. 2013 Sep;130(3):595-600. doi: 10.1016/j.ygyno.2013.06.005. Epub 2013 Jun 13.

16.

Reproducibility of linear array for human papillomavirus genotyping.

Koshiol J, Dunn ST, Walker JL, Zuna RE, Schiffman M, Sherman ME, Gold MA, Allen RA, Zhang R, Wang SS, Wentzensen N.

J Clin Microbiol. 2013 Feb;51(2):625-8. doi: 10.1128/JCM.03036-12. Epub 2012 Nov 28.

17.

The role of co-factors in the progression from human papillomavirus infection to cervical cancer.

Luhn P, Walker J, Schiffman M, Zuna RE, Dunn ST, Gold MA, Smith K, Mathews C, Allen RA, Zhang R, Wang S, Wentzensen N.

Gynecol Oncol. 2013 Feb;128(2):265-70. doi: 10.1016/j.ygyno.2012.11.003. Epub 2012 Nov 10.

18.

Pyrosequencing of IDH1 and IDH2 mutations in brain tumors and non-neoplastic conditions.

Cykowski MD, Allen RA, Fung KM, Harmon MA, Dunn ST.

Diagn Mol Pathol. 2012 Dec;21(4):214-20. doi: 10.1097/PDM.0b013e31825d802b.

PMID:
23111198
19.

A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: a Gynecologic Oncology Group study.

Carter RL, Kang L, Darcy KM, Kauderer J, Liao SY, Rodgers WH, Walker JL, Lankes HA, Dunn ST, Stanbridge EJ.

Cancer Causes Control. 2012 Dec;23(12):2013-21. doi: 10.1007/s10552-012-0081-0. Epub 2012 Oct 17.

20.

Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.

Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, Allen RA, Zhang R, Dunn ST, Walker JL, Schiffman M.

Clin Cancer Res. 2012 Aug 1;18(15):4154-62. doi: 10.1158/1078-0432.CCR-12-0270. Epub 2012 Jun 6.

21.

Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management.

Wentzensen N, Walker J, Schiffman M, Yang HP, Zuna RE, Dunn ST, Allen RA, Zhang R, Sherman M, Gold MA, Wang SS.

Int J Cancer. 2013 Jan 1;132(1):148-54. doi: 10.1002/ijc.27577. Epub 2012 Apr 30.

22.

Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16.

van der Marel J, Quint WG, Schiffman M, van de Sandt MM, Zuna RE, Dunn ST, Smith K, Mathews CA, Gold MA, Walker J, Wentzensen N.

Int J Cancer. 2012 Sep 15;131(6):E946-53. doi: 10.1002/ijc.27532. Epub 2012 Apr 16.

23.

Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens.

Wentzensen N, Gravitt PE, Long R, Schiffman M, Dunn ST, Carreon JD, Allen RA, Gunja M, Zuna RE, Sherman ME, Gold MA, Walker JL, Wang SS.

J Clin Microbiol. 2012 May;50(5):1564-70. doi: 10.1128/JCM.06240-11. Epub 2012 Feb 15.

24.

Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3.

Yang HP, Zuna RE, Schiffman M, Walker JL, Sherman ME, Landrum LM, Moxley K, Gold MA, Dunn ST, Allen RA, Zhang R, Long R, Wang SS, Wentzensen N.

PLoS One. 2012;7(1):e29051. doi: 10.1371/journal.pone.0029051. Epub 2012 Jan 13.

25.

HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer.

Zuna RE, Tuller E, Wentzensen N, Mathews C, Allen RA, Shanesmith R, Dunn ST, Gold MA, Wang SS, Walker J, Schiffman M.

Infect Agent Cancer. 2011 Oct 28;6:19. doi: 10.1186/1750-9378-6-19.

26.

Cytologic and molecular diagnosis of thyroid cancers: is it time for routine reflex testing?

Hassell LA, Gillies EM, Dunn ST.

Cancer Cytopathol. 2012 Feb 25;120(1):7-17. doi: 10.1002/cncy.20186. Epub 2011 Aug 31. Review.

27.

Detection of high-risk HPV in head and neck squamous cell carcinomas: comparison of chromogenic in situ hybridization and a reverse line blot method.

Stevens TM, Caughron SK, Dunn ST, Knezetic J, Gatalica Z.

Appl Immunohistochem Mol Morphol. 2011 Dec;19(6):574-8. doi: 10.1097/PAI.0b013e318215248a.

PMID:
21552119
28.

Comparison of 2 line blot assays for defining HPV genotypes in oral and oropharyngeal squamous cell carcinomas.

Shanesmith R, Allen RA, Moore WE, Kingma DW, Caughron SK, Gillies EM, Dunn ST.

Diagn Microbiol Infect Dis. 2011 Jun;70(2):240-5. doi: 10.1016/j.diagmicrobio.2011.01.011. Epub 2011 Mar 9.

PMID:
21392922
29.

Pharmacokinetic interaction of the antiparasitic agents ivermectin and spinosad in dogs.

Dunn ST, Hedges L, Sampson KE, Lai Y, Mahabir S, Balogh L, Locuson CW.

Drug Metab Dispos. 2011 May;39(5):789-95. doi: 10.1124/dmd.110.034827. Epub 2011 Feb 14.

PMID:
21321059
30.

Risk of cervical intraepithelial neoplasia 2+ among women with a history of previous treatment for cervical intraepithelial neoplasia: ASCUS and LSIL Pap smears after treatment.

Burks HR, Smith KM, Wentzensen N, Tenney M, Tuller E, Moxley K, Mathews C, Dunn ST, Wang SS, Gold MA.

J Low Genit Tract Dis. 2011 Jan;15(1):11-4. doi: 10.1097/LGT.0b013e3181ed3d6d.

31.

HPV genotype distribution in oral and oropharyngeal squamous cell carcinoma using seven in vitro amplification assays.

Kingma DW, Allen RA, Moore W, Caughron SK, Melby M, Gillies EM, Marlar RA, Dunn ST.

Anticancer Res. 2010 Dec;30(12):5099-104.

PMID:
21187496
32.

c-Kit expression and mutations in phyllodes tumors of the breast.

Bose P, Dunn ST, Yang J, Allen R, El-Khoury C, Tfayli A.

Anticancer Res. 2010 Nov;30(11):4731-6.

PMID:
21115932
33.

Competency-based education for the molecular genetic pathology fellow: a report of the association for molecular pathology training and education committee.

Talbert ML, Dunn ST, Hunt J, Hillyard DR, Mirza I, Nowak JA, Van Deerlin V, Vnencak-Jones CL.

J Mol Diagn. 2009 Nov;11(6):497-507. doi: 10.2353/jmoldx.2009.090040. Epub 2009 Oct 1.

34.

Accuracy of cervical specimens obtained for biomarker studies in women with CIN3.

Wentzensen N, Zuna RE, Sherman ME, Gold MA, Schiffman M, Dunn ST, Jeronimo J, Zhang R, Walker J, Wang SS.

Gynecol Oncol. 2009 Dec;115(3):493-6. doi: 10.1016/j.ygyno.2009.09.001. Epub 2009 Sep 20.

35.

Editors' introduction.

Ginocchio CC, Carman W, Shroyer KR, Dunn ST.

J Clin Virol. 2009 Jul;45 Suppl 1:S1. doi: 10.1016/S1386-6532(09)00331-X. No abstract available.

PMID:
19651362
36.

Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population.

Zuna RE, Moore WE, Shanesmith RP, Dunn ST, Wang SS, Schiffman M, Blakey GL, Teel T.

Int J Cancer. 2009 Dec 1;125(11):2609-13. doi: 10.1002/ijc.24706.

37.

Primer site polymorphisms: potential implications for bone marrow engraftment monitoring.

Seywerd K, Allen RA, Dunn ST.

Genet Test Mol Biomarkers. 2009 Jun;13(3):415-9. doi: 10.1089/gtmb.2008.0153.

PMID:
19405877
38.

Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.

Wang SS, Zuna RE, Wentzensen N, Dunn ST, Sherman ME, Gold MA, Schiffman M, Wacholder S, Allen RA, Block I, Downing K, Jeronimo J, Carreon JD, Safaeian M, Brown D, Walker JL.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):113-20. doi: 10.1158/1055-9965.EPI-08-0591.

39.

Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma.

Wentzensen N, Schiffman M, Dunn ST, Zuna RE, Walker J, Allen RA, Zhang R, Sherman ME, Wacholder S, Jeronimo J, Gold MA, Wang SS.

Int J Cancer. 2009 Feb 15;124(4):964-9. doi: 10.1002/ijc.23969.

40.

Evaluation of linear array human papillomavirus genotyping using automatic optical imaging software.

Jeronimo J, Wentzensen N, Long R, Schiffman M, Dunn ST, Allen RA, Walker JL, Gold MA, Zuna RE, Sherman ME, Wacholder S, Wang SS.

J Clin Microbiol. 2008 Aug;46(8):2759-65. doi: 10.1128/JCM.00188-08. Epub 2008 Jun 11.

41.

Fatal postpartum spontaneous liver rupture: case report and literature review.

Sutton BC, Dunn ST, Landrum J, Mielke G.

J Forensic Sci. 2008 Mar;53(2):472-5. doi: 10.1111/j.1556-4029.2008.00677.x. Review.

PMID:
18366583
42.

Distribution of human papillomavirus genotypes in invasive squamous carcinoma of the vulva.

Sutton BC, Allen RA, Moore WE, Dunn ST.

Mod Pathol. 2008 Mar;21(3):345-54. doi: 10.1038/modpathol.3801010. Epub 2008 Jan 11.

43.

Detection of the JAK2V617F mutation by asymmetric PCR and melt curve analysis.

Sutton BC, Allen RA, Zhao ZJ, Dunn ST.

Cancer Biomark. 2007;3(6):315-24.

PMID:
18048969
44.

A common 1317TC polymorphism in MTHFR can lead to erroneous 1298AC genotyping by PCR-RE and TaqMan probe assays.

Allen RA, Gatalica Z, Knezetic J, Hatcher L, Vogel JS, Dunn ST.

Genet Test. 2007 Summer;11(2):167-73.

PMID:
17627388
45.

DNA extraction: an understudied and important aspect of HPV genotyping using PCR-based methods.

Dunn ST, Allen RA, Wang S, Walker J, Schiffman M.

J Virol Methods. 2007 Jul;143(1):45-54. Epub 2007 Mar 30.

PMID:
17399803
46.

Relationship of the 1793G-A and 677C-T polymorphisms of the 5,10-methylenetetrahydrofolate reductase gene to coronary artery disease.

Kebert CB, Eichner JE, Moore WE, Schechter E, Yaoi T, Vogel S, Allen RA, Dunn ST.

Dis Markers. 2006;22(5-6):293-301.

47.
48.

Abnormal melt curve profile during prothrombin 20210G --> A analysis due to the 20209C --> T variant.

Dunn ST, Allen RA, Bates F, McNamara V, Comp P.

Blood Coagul Fibrinolysis. 2006 Oct;17(7):599-602.

PMID:
16988559
49.

Acute promyelocytic leukemia and constitutional trisomy 21.

Kurkjian C, Patel S, Kamble R, Dunn ST, Kern W, Kharfan-Dabaja MA.

Cancer Genet Cytogenet. 2006 Mar;165(2):176-9.

PMID:
16527614
50.

Genome variation of human papillomavirus types: phylogenetic and medical implications.

Bernard HU, Calleja-Macias IE, Dunn ST.

Int J Cancer. 2006 Mar 1;118(5):1071-6. Review.

Supplemental Content

Support Center